Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285808759> ?p ?o ?g. }
- W4285808759 endingPage "100263" @default.
- W4285808759 startingPage "100263" @default.
- W4285808759 abstract "In Birt–Hogg–Dubé (BHD) syndrome, germline loss-of-function mutations in the Folliculin (FLCN) gene lead to an increased risk of renal cancer. To address how FLCN inactivation affects cellular kinase signaling pathways, we analyzed comprehensive phosphoproteomic profiles of FLCNPOS and FLCNNEG human renal tubular epithelial cells (RPTEC/TERT1). In total, 15,744 phosphorylated peptides were identified from 4329 phosphorylated proteins. INKA analysis revealed that FLCN loss alters the activity of numerous kinases, including tyrosine kinases EGFR, MET, and the Ephrin receptor subfamily (EPHA2 and EPHB1), as well their downstream targets MAPK1/3. Validation experiments in the BHD renal tumor cell line UOK257 confirmed that FLCN loss contributes to enhanced MAPK1/3 and downstream RPS6K1/3 signaling. The clinically available MAPK inhibitor Ulixertinib showed enhanced toxicity in FLCNNEG cells. Interestingly, FLCN inactivation induced the phosphorylation of PIK3CD (Tyr524) without altering the phosphorylation of canonical Akt1/Akt2/mTOR/EIF4EBP1 phosphosites. Also, we identified that FLCN inactivation resulted in dephosphorylation of TFEB Ser109, Ser114, and Ser122, which may be linked to increased oxidative stress levels in FLCNNEG cells. Together, our study highlights differential phosphorylation of specific kinases and substrates in FLCNNEG renal cells. This provides insight into BHD-associated renal tumorigenesis and may point to several novel candidates for targeted therapies." @default.
- W4285808759 created "2022-07-19" @default.
- W4285808759 creator A5002267927 @default.
- W4285808759 creator A5018213217 @default.
- W4285808759 creator A5021614674 @default.
- W4285808759 creator A5036306422 @default.
- W4285808759 creator A5040085594 @default.
- W4285808759 creator A5043028071 @default.
- W4285808759 creator A5059528168 @default.
- W4285808759 creator A5059875786 @default.
- W4285808759 creator A5060499140 @default.
- W4285808759 creator A5060949896 @default.
- W4285808759 creator A5088927549 @default.
- W4285808759 creator A5091597289 @default.
- W4285808759 date "2022-09-01" @default.
- W4285808759 modified "2023-09-27" @default.
- W4285808759 title "Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB Phosphoserines" @default.
- W4285808759 cites W1552824037 @default.
- W4285808759 cites W1964261321 @default.
- W4285808759 cites W1970261657 @default.
- W4285808759 cites W1974203897 @default.
- W4285808759 cites W1981403280 @default.
- W4285808759 cites W1985266905 @default.
- W4285808759 cites W1990626198 @default.
- W4285808759 cites W2001215875 @default.
- W4285808759 cites W2030116438 @default.
- W4285808759 cites W2032848771 @default.
- W4285808759 cites W2036145275 @default.
- W4285808759 cites W2040210675 @default.
- W4285808759 cites W2043274355 @default.
- W4285808759 cites W2053439872 @default.
- W4285808759 cites W2075029926 @default.
- W4285808759 cites W2078184757 @default.
- W4285808759 cites W2079119292 @default.
- W4285808759 cites W2083087851 @default.
- W4285808759 cites W2091787667 @default.
- W4285808759 cites W2092050617 @default.
- W4285808759 cites W2095649059 @default.
- W4285808759 cites W2100484841 @default.
- W4285808759 cites W2100902550 @default.
- W4285808759 cites W2111352469 @default.
- W4285808759 cites W2114682634 @default.
- W4285808759 cites W2116095691 @default.
- W4285808759 cites W2125947965 @default.
- W4285808759 cites W2131844506 @default.
- W4285808759 cites W2132463881 @default.
- W4285808759 cites W2133336565 @default.
- W4285808759 cites W2139429540 @default.
- W4285808759 cites W2139948451 @default.
- W4285808759 cites W2141444851 @default.
- W4285808759 cites W2145372108 @default.
- W4285808759 cites W2146228871 @default.
- W4285808759 cites W2146512944 @default.
- W4285808759 cites W2149828323 @default.
- W4285808759 cites W2153188271 @default.
- W4285808759 cites W2162857699 @default.
- W4285808759 cites W2168259122 @default.
- W4285808759 cites W2169194081 @default.
- W4285808759 cites W2256296785 @default.
- W4285808759 cites W2331705072 @default.
- W4285808759 cites W2569600607 @default.
- W4285808759 cites W2613001515 @default.
- W4285808759 cites W2626522201 @default.
- W4285808759 cites W2731594787 @default.
- W4285808759 cites W2753351580 @default.
- W4285808759 cites W2770072380 @default.
- W4285808759 cites W2792597015 @default.
- W4285808759 cites W2803875384 @default.
- W4285808759 cites W2806820493 @default.
- W4285808759 cites W2807198924 @default.
- W4285808759 cites W2809618310 @default.
- W4285808759 cites W2810352317 @default.
- W4285808759 cites W2886709152 @default.
- W4285808759 cites W2900253406 @default.
- W4285808759 cites W2904372598 @default.
- W4285808759 cites W2922277630 @default.
- W4285808759 cites W2949603991 @default.
- W4285808759 cites W2980164311 @default.
- W4285808759 cites W2981343343 @default.
- W4285808759 cites W2982402173 @default.
- W4285808759 cites W2982601264 @default.
- W4285808759 cites W2989525167 @default.
- W4285808759 cites W3005522330 @default.
- W4285808759 cites W3008092645 @default.
- W4285808759 cites W3008680167 @default.
- W4285808759 cites W3040600898 @default.
- W4285808759 cites W3044903726 @default.
- W4285808759 cites W3059618284 @default.
- W4285808759 cites W3087683516 @default.
- W4285808759 cites W3109082402 @default.
- W4285808759 cites W3111521801 @default.
- W4285808759 cites W3123673857 @default.
- W4285808759 cites W3156859314 @default.
- W4285808759 cites W3178500894 @default.
- W4285808759 cites W4221037022 @default.
- W4285808759 cites W4226295940 @default.
- W4285808759 cites W4237816489 @default.
- W4285808759 cites W4292820908 @default.